NO934003L - cyclopeptides - Google Patents

cyclopeptides

Info

Publication number
NO934003L
NO934003L NO934003A NO934003A NO934003L NO 934003 L NO934003 L NO 934003L NO 934003 A NO934003 A NO 934003A NO 934003 A NO934003 A NO 934003A NO 934003 L NO934003 L NO 934003L
Authority
NO
Norway
Prior art keywords
asp
arg
ala
gly
denotes
Prior art date
Application number
NO934003A
Other languages
Norwegian (no)
Other versions
NO309864B1 (en
NO934003D0 (en
Inventor
Alfred Dr Jonczyk
Guenter Dr Hoelzemann
Brunhilde Dr Felding-Habermann
Friedrich Dr Rippmann
Guido Dr Melzer
Beate Diefenbach
Horst Prof Dr Kessler
Roland Haubner
Jochen Wermuth
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO934003D0 publication Critical patent/NO934003D0/en
Publication of NO934003L publication Critical patent/NO934003L/en
Publication of NO309864B1 publication Critical patent/NO309864B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to novel cyclopeptides of the formula I Cyclo-(A-B-C-D-Arg) I in which A and B in each case independently of one another denote Ala, Asn, Asp, Arg, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr or Val, C denotes Asp or Asp(O-C1-4-alkyl) and D denotes Gly or Ala, at least two of the amino acid radicals indicated being present in the D-form, and their salts. These compounds act as integrin inhibitors and can be used in particular for the prophylaxis and treatment of circulation disorders and in tumour therapy.
NO934003A 1992-11-06 1993-11-05 Cyclopeptides, processes for their preparation, pharmaceutical preparations, processes for their preparation, and the use of compounds for the preparation of medicinal products NO309864B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237456A DE4237456A1 (en) 1992-11-06 1992-11-06 cyclopeptides

Publications (3)

Publication Number Publication Date
NO934003D0 NO934003D0 (en) 1993-11-05
NO934003L true NO934003L (en) 1994-05-09
NO309864B1 NO309864B1 (en) 2001-04-09

Family

ID=6472232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934003A NO309864B1 (en) 1992-11-06 1993-11-05 Cyclopeptides, processes for their preparation, pharmaceutical preparations, processes for their preparation, and the use of compounds for the preparation of medicinal products

Country Status (21)

Country Link
EP (1) EP0596350B1 (en)
JP (1) JP3681764B2 (en)
KR (1) KR100238894B1 (en)
CN (1) CN1038751C (en)
AT (1) ATE154037T1 (en)
AU (1) AU666586B2 (en)
CA (1) CA2102447C (en)
CZ (1) CZ286170B6 (en)
DE (2) DE4237456A1 (en)
DK (1) DK0596350T3 (en)
ES (1) ES2105041T3 (en)
GR (1) GR3024550T3 (en)
HU (1) HU215600B (en)
MX (1) MX9306885A (en)
NO (1) NO309864B1 (en)
PL (1) PL177772B1 (en)
RU (1) RU2129563C1 (en)
SK (1) SK280597B6 (en)
TW (1) TW340849B (en)
UA (1) UA43822C2 (en)
ZA (1) ZA938281B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6944221B2 (en) * 2017-11-20 2021-10-06 ノブメタファーマ カンパニー リミテッド Composition for prevention, amelioration or treatment of bone loss disease containing CHP (cyclo-hispro)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents

Also Published As

Publication number Publication date
MX9306885A (en) 1995-01-31
HU215600B (en) 1999-01-28
TW340849B (en) 1998-09-21
CN1093090A (en) 1994-10-05
DE59306654D1 (en) 1997-07-10
PL177772B1 (en) 2000-01-31
KR940011479A (en) 1994-06-21
KR100238894B1 (en) 2000-01-15
SK280597B6 (en) 2000-04-10
CZ286170B6 (en) 2000-02-16
EP0596350B1 (en) 1997-06-04
RU2129563C1 (en) 1999-04-27
ES2105041T3 (en) 1997-10-16
NO309864B1 (en) 2001-04-09
DE4237456A1 (en) 1994-05-11
JPH0892282A (en) 1996-04-09
NO934003D0 (en) 1993-11-05
PL300935A1 (en) 1994-05-16
ZA938281B (en) 1994-06-07
ATE154037T1 (en) 1997-06-15
AU666586B2 (en) 1996-02-15
UA43822C2 (en) 2002-01-15
CZ235293A3 (en) 1994-07-13
EP0596350A1 (en) 1994-05-11
CA2102447C (en) 2007-04-10
JP3681764B2 (en) 2005-08-10
GR3024550T3 (en) 1997-12-31
CN1038751C (en) 1998-06-17
DK0596350T3 (en) 1997-12-29
HUT68321A (en) 1995-06-28
AU5039993A (en) 1994-05-19
CA2102447A1 (en) 1994-05-07
SK121793A3 (en) 1995-06-07

Similar Documents

Publication Publication Date Title
CA2120303A1 (en) Cyclic adhesion inhibitors
ES2144179T3 (en) CYCLIC ADHESION INHIBITORS.
NZ248377A (en) Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors
PT804252E (en) METALLIC CHELTER AGENTS THAT CONTAINS DIAMOND MONOAMINES AND THIOIS
MX9703621A (en) Novel amino acid derivatives with improved multi-drug resistance activity.
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
ATE211384T1 (en) USE OF ADENOSINE ANTAGONISTS TO PREVENT AND TREAT PANCREATITIS AND ULCERAS
ATE251140T1 (en) N-(2OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBONIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY
DE69230046D1 (en) 2-bromomelatonin for the treatment of sleep disorders
UA41355C2 (en) Agent for treating neuro-aids
DE69936381D1 (en) USE OF A PROTEIN KINASE HEMMER LIKE. GENISTE IN THE TREATMENT OF DIABETIC RETINOPATHY
CA2148194A1 (en) Cyclopeptides of the formula i
IS2819B (en) Vascular adhesion molecules and formulation of their activity @
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
ES2106531T3 (en) DIBENZOXAZEPINE COMPOUNDS SUBSTITUTED IN 2, 3, 4, 5, 6, 7, 8, 9 AND / OR 10, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
DE3852935D1 (en) Substituted alpha amino acids with pharmaceutical activity.
NO941151L (en) Linear adhesion inhibitors
ES2105041T3 (en) CYCLOPEPTIDES.
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
YU60199A (en) New bpc peptide salts with organo-protective activity,the process for their preparation and their use in therapy
DK0613375T3 (en) Pharmaceutical lysine-containing polypeptide preparations and their use
RU95120588A (en) CYCLOGEXAEPEPTIDES, THEIR MIXTURES, METHOD FOR PRODUCING AND USING THEM
EP0248231A3 (en) Pharmacologically active peptides
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
DE59410340D1 (en) Use of bradykinin antagonists to treat viral diseases